Histological and micro-CT evaluations revealed that RA fractures treated with PCL scaffolds encapsulating dCas9-Dnmt3a-scramble cells were characterized by the persistence of mesenchymal tissue and the absence of a unified rigid structure (Figure 7, B–E). Here, DNMT3A is linked to rheumatoid arthritis.